Augmedix (AUGX) Stock Price
Augmedix Price
Revenue has compounded at 33.5% per year over the past 4 years to 44.86 M USD. Augmedix's net margin stands at -42.7%, up from -158.5% several years earlier. Analysts set a median price target of 2.98 USD, implying 27.0% above the current price. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus.
Augmedix stock price
Augmedix business model & stock analysis
Frequently asked questions about Augmedix
The business model of Augmedix Inc revolves around providing remote medical scribe services to healthcare providers. Augmedix utilizes wearable technology, such as smart glasses, to capture and transmit real-time patient data to professional medical scribes. These scribes then document and transcribe the patient-physician interaction, allowing doctors to focus on patient care. Augmedix's innovative approach enhances physician productivity, reduces administrative burden, and improves healthcare services. By harnessing technology to optimize documentation, Augmedix enables more efficient and accurate patient record-keeping, ultimately leading to improved patient outcomes and streamlined workflows for healthcare providers.
Augmedix Inc is primarily active in the healthcare industry.
The main competitors of Augmedix Inc in the market are companies like Doximity, Notable, PrognoCIS, and Suki.
Augmedix Inc is a leading healthcare technology company specialized in providing documentation solutions for doctors and physicians. Founded in 2012, Augmedix has revolutionized the healthcare industry by introducing a unique platform that enables healthcare professionals to focus more on patient care, rather than administrative tasks. Through their innovative technology, the company has successfully integrated artificial intelligence and virtual scribes to streamline the documentation process, improving efficiency and accuracy in medical records. Augmedix Inc has gained recognition for its transformative solutions, partnering with over 1,000 healthcare organizations worldwide. With its commitment to enhancing patient care, Augmedix continues to spearhead advancements in healthcare documentation services.
Augmedix Inc has achieved several significant milestones. Firstly, the company secured major funding rounds, raising a total of $90 million in investment. Secondly, Augmedix expanded its operations by partnering with leading healthcare providers and successfully implementing its virtual medical documentation platform. Thirdly, the company received recognition and awards, including being named one of the Most Innovative Companies in Healthcare by Fast Company. Additionally, Augmedix has witnessed substantial growth with its platform being used by healthcare professionals across numerous clinics and hospitals. These milestones highlight Augmedix Inc's success in revolutionizing the healthcare industry with its innovative technology and services.
Augmedix Inc is primarily present in the United States.
Augmedix Inc represents values of innovation, efficiency, and patient-centricity. As a leading provider of remote medical documentation services, Augmedix is committed to revolutionizing healthcare through the use of advanced technology. The company's corporate philosophy revolves around enhancing the healthcare experience for both patients and providers. Augmedix leverages its proprietary platform to streamline clinical workflows, allowing healthcare professionals to focus on delivering high-quality care. By embracing a patient-centric approach, the company aims to improve access to healthcare services, reduce administrative burdens, and ultimately enhance patient outcomes. Augmedix Inc's dedication to innovation and efficiency sets it apart in the rapidly evolving digital healthcare industry.
Analysts currently set an average price target of 3.60 USD for the Augmedix stock (median: 2.98 USD), implying +53.0 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Augmedix stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Augmedix to generate revenue of 62.00 M USD and earnings per share of -0.35 USD.
Converted at the current exchange rate, the Augmedix share trades at 2.10 EUR (2.35 USD).
The Augmedix share (AUGX) is listed on 1 stock exchanges, including: NASDAQ (AUGX).
Augmedix Inc is a leading company in the field of medical records and workflow improvement. The company's business model is based on the implementation of virtual reality (VR) and artificial intelligence (AI) for the automatic creation of medical documentation. Augmedix specializes in efficiently serving doctor's offices, hospitals, and insurance companies. Augmedix's main product is an intuitive application that allows doctors to treat their patients more efficiently and quickly by reviewing medical records and providing diagnoses and treatments. The use of VR technology allows medical professionals to access relevant information while interacting with patients. Augmedix's AI saves doctors time and increases efficiency by automatically performing necessary steps while doctors focus on treating patients. The company also offers additional services and support to facilitate the integration of their technology into existing practice and workflow. By improving the efficiency and accuracy of medical documentation, Augmedix helps doctors increase productivity and optimize patient care. Additionally, Augmedix's technology saves time and costs for practice management, improving the operation of doctor's offices and hospitals. Augmedix also provides specialized training to educate medical professionals in VR technology and AI. The company has partnerships with major healthcare organizations such as Sutter Health and Dignity Health to implement the technology and enhance patient care. Augmedix's business model is based on a subscription model, where customers pay for access to the technology and related services. The average price for a monthly subscription is around $2,500 per doctor. The company is able to achieve high margins due to the high value of its services, the high quality of its technology, and the high demand for automation of medical records. Augmedix Inc is also expanding internationally and has already offered services in Canada, the UK, and Australia. The company has a strategic partnership with Google to further improve and expand its technology. It has also become a central element in the telehealth market, which has gained importance during the COVID-19 pandemic. In summary, Augmedix Inc's business model specializes in improving workflows in healthcare and automating medical records. Augmedix's technology is based on VR and AI to help doctors and medical professionals perform their work more efficiently and accurately. The company offers a variety of services and training to integrate its technology into existing practice and workflow. Augmedix's subscription model allows the company to achieve high margins and competitive advantages in a rapidly growing market.
The expected revenue of Augmedix is 62.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Augmedix is -17.30 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Augmedix is currently -6.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Augmedix stock.
The price-to-sales ratio (P/S) of Augmedix is currently 1.86. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Augmedix stock.
The Eulerpool Quality Score for Augmedix is 3/10.
The ISIN of Augmedix is US05105P1075. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Augmedix is AUGX. The ticker symbol is used to trade Augmedix shares on the stock exchange.
Augmedix stock
Augmedix Peer Group
Augmedix Ticker
Augmedix FIGI
All fundamentals and in-depth analysis of Augmedix
Our stock analysis for Augmedix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Augmedix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.